Pharmaceutical Sciences
Research Agricultural
Total number of Record(s): 172
| Title | Principal Investigator | Start Year | Funding Agency | Research Area |
|---|---|---|---|---|
| A Multiscale Study of Photoswitchable Drugs for Optimal Control of G-Protein Coupled Receptors | Dr. Padmabati Mondal, Indian Institute of Science Education and Research (IISER) Tirupati, Andhra Pradesh | 2024 | Anusandhan National Rsearch Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |
| Controlled Polymer- Insulin interaction in the Transdermal Insulin Drug Delivery system | Prof. Sudip K Pattanayek, Indian Institute Of Technology (IIT) Delhi | 2024 | Anusandhan National Rsearch Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |
| Determination of In Vivo Effective Diffusion Rates of Therapeutics from Controlled Release Systems | Dr. Siddharth Jhunjhunwala, Indian Institute Of Science, Bangalore, Karnataka | 2024 | Anusandhan National Rsearch Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |
| A clinical drug development programme to evaluate and compare the safety and efficacy of new regimens of Lifecare's Liposomal Amphotericin b (FUNGISOMETM) against currently accepted therapies for the treatment of Kala Azar; A Phase III, Open Label Randomized Trial of Three Single Dose Treatment regimens of FUNGISOMETM ALONE OR IN Combination with Miltefosine compared with single Dose Treatment regimen of AmBisome for visceral Leishmaniasis in India | Dr. J N Verma, Lifecare Innovations Private Limited, Gurgaon, Haryana (122018) | 2024 | Department of Science and Technology (DST) | Pharmaceutical Sciences |
| Stereoselective Synthesis of Structurally Diverse Sp3-rich Polycyclic Scaffolds: Generation of High valued New Molecular Entities (NMEs) for GPCR Modulators | Dr. Ravindra Kumar, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow, Uttar Pradesh | 2024 | Anusandhan National Research Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |
| Dual-targeted novel combination therapy for triple-negative breast cancer | Dr. Shashank Kumar, Central University Of Punjab, Bathinda, Punjab | 2024 | Anusandhan National Research Foundation/ Science and Engineering Research Board | Pharmaceutical Sciences |
| Water-soluble Ru(II) and Pd(II) Porphyrins as Novel Photosensitizers for Photodynamic Therapy | Dr. Tridib Kumar Goswami, Gauhati University, Assam | 2024 | Anusandhan National Research Foundation/ Science and Engineering Research Board | Pharmaceutical Sciences |
| Exploration of Cyclic Diaryliodonium Salts as Biarylating Agents to Generate Medicinally Relevant Biaryl | Dr. Malleswara Rao Kuram, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow, Uttar Pradesh | 2024 | Anusandhan National Research Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |
| Multiepitope nanoglycoconjugate vaccine development against Mycobacterium tuberculosis | Dr. Jairam Meena, Indian Institute Of Technology (BHU), Uttar Pradesh | 2024 | Anusandhan National Rsearch Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |
| In silico discovery and biological evaluation of potential drug molecules to improve the treatment of Bedaquiline and Delamanid resistance in Mycobacterium tuberculosis. | Dr. Shalini Saxena, University of Hyderabad, Telangana (500046) | 2024 | Department of Science and Technology (DST) | Pharmaceutical Sciences |